unknown
Stage
1
Investors
About
Capricor Therapeutics is a clinical-stage biotechnology company developing cell- and exosome-based therapies for cardiac and muscular diseases. Its programs have included allogeneic cardiosphere-derived cells and exosome approaches targeting heart repair and Duchenne muscular dystrophy.
Explore Capricor Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.